Modulation of fibrinolysis by the combined action of phospholipids and immunoglobulins

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Judit GombásKrasimir Kolev

Abstract

Because both immunoglobulin G (IgG) and phospholipids interfere with fibrinolysis, their combined modulating effects were investigated in experimental models of three consecutive steps of the fibrinolytic process [diffusion of tissue-type plasminogen activator (tPA) into the clot, plasminogen activation on fibrin surface and fibrin dissolution by plasmin] using IgGs isolated from healthy subjects and from patients with antiphospholipid syndrome in combination with mixtures of synthetic dipalmitoylphosphatidylcholine and dipalmitoylphosphatidylserine. In fibrin clots containing phospholipids the normal IgG enhanced the barrier function of the phospholipids with respect to the diffusion of tPA and plasminogen activation, but did not modify the lysis by plasmin. One of the examined antiphospholipid syndrome-IgGs also restricted the diffusion of tPA, but it accelerated the plasminogen activation on the fibrin surface and slowed down the lysis of fibrin by plasmin. Another antiphospholipid syndrome IgG, which did not affect significantly the tPA penetration into the fibrin gel, did not modify the plasminogen activation on its own, but it partially opposed the inhibiting effect of phospholipids on plasmin formation and accelerated th...Continue Reading

References

Aug 4, 1980·Clinica Chimica Acta; International Journal of Clinical Chemistry·P JouanelB Dastugue
Jan 1, 1996·Annual Review of Medicine·S S Shapiro
Jul 1, 1996·The Journal of Laboratory and Clinical Medicine·M E CarrS L Carr
Dec 12, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K K HwangP P Chen
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Cheng-De YangPojen P Chen
Jul 16, 2004·The Journal of Biological Chemistry·Balázs VáradiRaymund Machovich
Aug 12, 2004·Journal of Thrombosis and Haemostasis : JTH·C Longstaff, C M Whitton
Oct 28, 2004·Thrombosis Research·Shinsuke YasudaTakao Koike

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.